Stock Scorecard
Stock Summary for Atyr Pharma Inc (LIFE) - $1.20 as of 12/8/2023 9:09:28 PM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for LIFE
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LIFE
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LIFE
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for LIFE
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for LIFE
Financial Details for LIFE
Company Overview |
|
|---|---|
| Ticker | LIFE |
| Company Name | Atyr Pharma Inc |
| Country | USA |
| Description | aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| Most Recent Quarter | 9/30/2023 |
| Next Earnings Date | 3/7/2024 |
Stock Price History |
|
| Last Day Price | 1.20 |
| Last Day Price Updated | 12/8/2023 9:09:28 PM EST |
| Last Day Volume | N/A |
| Average Daily Volume | N/A |
| 52-Week High | 2.70 |
| 52-Week Low | 1.08 |
| Last Price to 52 Week Low | 11.11 % |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 158.38 |
| Sector PE | 62.37 |
| 5-Year Average PE | -2.12 |
| Free Cash Flow Ratio | 0.69 |
| Industry Free Cash Flow Ratio | 17.89 |
| Sector Free Cash Flow Ratio | 31.15 |
| Current Ratio Most Recent Quarter | 8.33 |
| Total Cash Per Share | 1.74 |
| Book Value Per Share Most Recent Quarter | 1.68 |
| Price to Book Ratio | 0.72 |
| Industry Price to Book Ratio | 4.65 |
| Sector Price to Book Ratio | 19.59 |
| Price to Sales Ratio Twelve Trailing Months | 6.54 |
| Industry Price to Sales Ratio Twelve Trailing Months | 16.60 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.61 |
Share Statistics |
|
| Total Shares Outstanding | 58,560,000 |
| Market Capitalization | 70,272,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Dividend King? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00 % |
| 5-Year Dividend Payments Count | 0 |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00 % |
| Annual Earnings Growth | -34.26 % |
| Reported EPS 12 Trailing Months | -0.95 |
| Reported EPS Past Year | -0.71 |
| Reported EPS Prior Year | -1.60 |
| Net Income Twelve Trailing Months | -43,150,000 |
| Net Income Past Year | -45,338,000 |
| Net Income Prior Year | -33,768,000 |
| Quarterly Revenue Growth YOY | 1,326.00 % |
| 5-Year Revenue Growth | 0.00 % |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 102,131,000 |
| Total Cash Past Year | 66,146,000 |
| Total Cash Prior Year | 107,911,000 |
| Net Cash Position Most Recent Quarter | 102,131,000 |
| Net Cash Position Past Year | 66,146,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 71,464,000 |
| Total Stockholder Equity Prior Year | 109,301,000 |
| Total Stockholder Equity Most Recent Quarter | 98,390,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.01 |
| MACD Signal | -0.02 |
| 20-Day Bollinger Lower Band | 0.93 |
| 20-Day Bollinger Middle Band | 1.53 |
| 20-Day Bollinger Upper Band | 2.14 |
| Beta | 1.20 |
| RSI | 51.58 |
| 50-Day SMA | 1.95 |
| 200-Day SMA | 3.85 |
System |
|
| Modified | 12/9/2023 1:32:11 PM EST |